EMA Authorised: Tecovirimat SIGA (tecovirimat) — SIGA Technologies Netherlands B.V.

View source ↗

Summary

The EMA authorised tecovirimat (brand SIGA) for treatment of orthopoxvirus infections including cowpox, monkeypox, vaccinia infection, and smallpox, with SIGA T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cowpox
• Monkeypox
• Smallpox
• Vaccinia Infection

Drugs mentioned

• Tecovirimat SIGA (tecovirimat)

Snippet

Status: Authorised. Therapeutic area: Poxviridae Infections;Cowpox;Monkeypox;Vaccinia;Smallpox. MAH: SIGA Technologies Netherlands B.V.. Decision date: 02/10/2024